There are several strategies to mitigate adverse biological interactions. One approach is to carefully design nanomaterials with biocompatible coatings or functional groups that reduce toxicity. Another method is to conduct thorough preclinical testing to assess the safety of nanomaterials before their widespread use. Regulatory guidelines and standards can also help ensure the safe development and application of nanotechnologies.
